Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects

Name: Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects
SKU: 2835
Price: 30.00 USD
Availability: InStock

$30.00

Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects

Jeffrey L. Cummings, MD and Dilip V. Jeste, MD

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 4 Articles Tags: alzheimers, dilip-v-jeste, fda, jeffrey-l-cummings, labeling, neuropsychiatric, nimh, pharmacotherapy, pharmacotherapy-of-neuropsychiatric-syndromes, pseudospecificity

Description

Description

Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects

Jeffrey L. Cummings, MD and Dilip V. Jeste, MD

PB-40-4-06-CUMMINGS

Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects

Description

Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

VOL 2 No. 12 Full Issue – December 2000

Schizophrenia and Valproate

Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety

Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects

Description

Related products

Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

VOL 2 No. 12 Full Issue – December 2000

Schizophrenia and Valproate

Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety